# Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker

> **NCT06489951** · NA · COMPLETED · sponsor: **Xing Liu** · enrollment: 180 (actual)

## Conditions studied

- Overactive Bladder
- Pediatric Disorder

## Interventions

- **DRUG:** Solifenacin
- **DIETARY_SUPPLEMENT:** vitamin D
- **BEHAVIORAL:** Standard behavioral therapy

## Key facts

- **NCT ID:** NCT06489951
- **Lead sponsor:** Xing Liu
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-12-28
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-03
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06489951

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06489951, "Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06489951. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*